08:35 AM EDT, 08/12/2024 (MT Newswires) -- Masimo ( MASI ) said Monday its Masimo W1 medical watch has received the US Food and Drug Administration's clearance to integrate it with the Masimo SafetyNet comprehensive telemonitoring solution.

The integration provides improved patient data through the wrist, which will be available on the Masimo SafetyNet smartphone app and its web-based clinician portal, the medical technology company added.

The Masimo SafetyNet system also connects with other wearables, including Masimo Radius PPG for tetherless fingertip pulse oximetry and Radius T for wireless thermometry, the company said.

The regulator cleared Masimo W1 Medical in 2023 as a medical watch for providing oxygen saturation and pulse rate for over-the-counter and prescription use at home and in hospitals.